Patents by Inventor Lingyun Wu

Lingyun Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11965919
    Abstract: A phase frequency detector-based high-precision feedback frequency measurement apparatus and method: a Field Programmable Gate Array (FGPA) roughly measures a frequency fx of a measured time-frequency pulse by an equal-precision frequency measurement method; a Direct Digital Synthesizer (DDS) automatically synthesizes a frequency fx? according to the fx roughly measured by the FPGA; the fx and the fx? are sent to a phase frequency detector for performing phase frequency detection and then sent to the FPGA after passing through a charge pump, a low-pass filter circuit, and an (Analogue-to-Digital) A/D converter; the FPGA processes a frequency difference obtained by the phase frequency detector and then transmits the processed frequency difference to the DDS to form a negative feedback frequency measurement system so that the DDS continuously adjusts the fx? according to a frequency difference measurement result until the output of the DDS is stable.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: April 23, 2024
    Assignee: Zhejiang University
    Inventors: Xinglin Sun, Haojie Wu, Xinyue Tan, Lingyun Ye
  • Publication number: 20240116606
    Abstract: This disclosure provides an unmanned survey vessel with an anti-overturning structure and an anti-overturning method of same, and relates to the anti-overturning technique field of unmanned survey vessels. The unmanned survey vessel includes a vessel body and a plurality of buoys. The vessel body is a hollow frame of which a middle is provided with a discharge space. An uptight rod is vertically fixed at an upper-end of the tail part of the vessel body. A supporting beam is horizontally fixed at an upper-end of the upright rod. The supporting beam extends to a bow of the vessel. A rectangular notch is formed in one end, close to the bow, of the supporting beam. One end close to the bow inside the rectangular notch is rotatably provided with a guide rod through a pin shaft. The plurality of buoys are equally divided into two groups which are adjustably arranged on two side walls in the advancing direction of the vessel body respectively.
    Type: Application
    Filed: June 26, 2023
    Publication date: April 11, 2024
    Inventors: Jiudong YANG, Fenghua WU, Muyao SHI, Lingyun ZHANG, Liwen YIN, Gui'e TIAN, Jinliang HOU, Lipeng GONG
  • Publication number: 20240102834
    Abstract: An easy-to-assemble mounting rack for a deformation detection device for a steel structure and an assembling method thereof are provided. The easy-to-assemble mounting rack includes mounting parts including a back mounting plate, an operating rod, an adjusting seat, a ball-shaped block and an upright rod. The upright rod is vertically fixed at the bottom end face of the adjusting seat. A ball-shaped hole is formed in the adjusting seat. The ball-shaped block is rotatably embedded in the ball-shaped hole. A plug-in hole is formed in a radial direction of the ball-shaped block. One end of the operating rod slidably penetrates through the plug-in hole and is detachably connected with the back mounting plate. Screw holes directly opposite to the mounting holes of the deformation detection device are formed on the back mounting plate. The other end of the operating rod is fixedly sleeved with a counterweight plate.
    Type: Application
    Filed: June 23, 2023
    Publication date: March 28, 2024
    Inventors: Jiudong YANG, Fenghua WU, Muyao SHI, Lingyun ZHANG, Liwen YIN, Gui'e TIAN, Jinliang HOU, Lipeng GONG
  • Publication number: 20230331696
    Abstract: Disclosed is a salt form of an isoquinolinone type compound as a ROCK protein kinase inhibitor and a preparation method therefor, and use of the salt form in the preparation of a medicament for treating glaucoma or ocular hypertension is further included.
    Type: Application
    Filed: June 21, 2023
    Publication date: October 19, 2023
    Inventors: Jian GE, Yandong WANG, Yizhi LIU, Lingyun WU, Xu YOU, Zheming XIAO, Shuhui CHEN
  • Publication number: 20230295076
    Abstract: Disclosed are an acetophenone oxime compound and a preparation method therefor, and specifically disclosed are a compound as shown in formula (II) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 16, 2021
    Publication date: September 21, 2023
    Inventors: Lingyun Wu, Lele Zhao, Xinming Du, Xu You, Shuhui Chen
  • Patent number: 11760751
    Abstract: Disclosed are a series of benzo 2-azaspiro[4.4]nonane compounds, and specifically disclosed are a compound as represented by formula (P) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 2, 2021
    Date of Patent: September 19, 2023
    Assignee: HELIOEAST SCIENCE & TECHNOLOGY CO., LTD.
    Inventors: Lingyun Wu, Peng Yang, Lele Zhao, Xu You, Jian Li, Shuhui Chen
  • Patent number: 11702400
    Abstract: Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors. Specifically, disclosed are hydrochloride and acetate of compounds of formula (I) and crystal forms thereof, as well as application of the salt types and the crystal forms in preparation of RHO inhibitor drugs.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: July 18, 2023
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Lingyun Wu, Zheming Xiao, Chunyan Jiang, Jian Li, Shuhui Chen
  • Patent number: 11649245
    Abstract: Provided is a cyclopropylamine compound as lysine-specific demethylase 1 (LSD1) inhibitor, and a use thereof in preparation of drug for treating diseases associated with LSD1. The cyclopropylamine compound is a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: May 16, 2023
    Assignees: HELIOEAST PHARMACEUTICAL CO., LTD., Helioeast Science & Technology Co., Ltd.
    Inventors: Lingyun Wu, Qiuyan Wang, Jian Li, Shuhui Chen
  • Publication number: 20230126480
    Abstract: Disclosed are a series of benzo 2-azaspiro[4.4]nonane compounds, and specifically disclosed are a compound as represented by formula (P) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 2, 2021
    Publication date: April 27, 2023
    Applicants: HELIOEAST PHARMACEUTICAL CO., LTD., HELIOEAST SCIENCE & TECHNOLOGY CO., LTD.
    Inventors: Lingyun WU, Peng YANG, Lele ZHAO, Xu YOU, Jian LI, Shuhui CHEN
  • Publication number: 20230124301
    Abstract: Disclosed in the present invention are a series of tricyclic compounds, and particularly disclosed are a compound shown in formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 2, 2021
    Publication date: April 20, 2023
    Applicants: HELIOEAST PHARMACEUTICAL CO., LTD., HELIOEAST SCIENCE & TECHNOLOGY CO., LTD.
    Inventors: Lingyun WU, Peng YANG, Lele ZHAO, Jian LI, Shuhui CHEN
  • Publication number: 20230024516
    Abstract: Disclosed are a series of isoquinolone derivatives as ROCK protein kinase inhibitors and uses thereof in preparing medicaments for ROCK protein kinase inhibitor-related glaucoma or ocular hypertension diseases. Specially, disclosed are a compound of formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 22, 2020
    Publication date: January 26, 2023
    Applicant: GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO., LTD.
    Inventors: Yizhi Liu, Yandong Wang, Lingyun Wu, Xu You, Zheming Xiao, Shuhui Chen
  • Publication number: 20220415007
    Abstract: Methods, systems, electronic devices, and computer-readable storage media for image normalization processing are provided. In one aspect, an image normalization processing method includes: normalizing a feature map by respectively using K normalization factors to obtain K candidate normalized feature maps; for each of the K normalization factors, determining a first weight value for the normalization factor; and determining a target normalized feature map corresponding to the feature map based on the candidate normalized feature map corresponding to each of the K normalization factors and the first weight value for each of the K normalization factors. The K candidate normalized feature maps and the K normalization factors have a one-to-one correspondence, and K is an integer greater than 1.
    Type: Application
    Filed: August 23, 2022
    Publication date: December 29, 2022
    Inventors: Ruimao ZHANG, Zhanglin PENG, Lingyun WU, Ping LUO
  • Publication number: 20220402917
    Abstract: A biaryl compound. Specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 30, 2020
    Publication date: December 22, 2022
    Inventors: Lingyun WU, Cailin WANG, Xiongbin XU, Haijun TONG, Shuhui CHEN
  • Patent number: 11524941
    Abstract: Disclosed are a class of pyrazole compounds and applications thereof in the preparation of a medicament for treating related diseases. Specifically, related are a compound represented by formula (II) and a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: December 13, 2022
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Lingyun Wu, Lele Zhao, Jianjun Sun, Zhen Zhan, Shuhui Chen
  • Publication number: 20220380336
    Abstract: Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors. Specifically, disclosed are hydrochloride and acetate of compounds of formula (I) and crystal forms thereof, as well as application of the salt types and the crystal forms in preparation of RHO inhibitor drugs.
    Type: Application
    Filed: October 16, 2020
    Publication date: December 1, 2022
    Inventors: Lingyun WU, Zheming XIAO, Chunyan JIANG, Jian LI, Shuhui CHEN
  • Patent number: 11465995
    Abstract: Provided are a crystal form of a tricyclic compound and a preparation process thereof. Also provided is an application of the crystal form in preparing a drug for treating a disease related to a sphingosine-1-phosphate subtype 1 (S1P1) receptor.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: October 11, 2022
    Assignee: Medshine Discovery Inc.
    Inventors: Peng Zhang, Weidong Li, Lingyun Wu
  • Publication number: 20220281895
    Abstract: Disclosed are pyrrolotriazine compounds which act as a mitogen-activated protein kinase interacting kinase (MNK) inhibitor, and the use thereof in the preparation of a mitogen-activated protein kinase interacting kinase inhibitor drug. Specifically disclosed are compounds represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 18, 2022
    Publication date: September 8, 2022
    Inventors: Lingyun WU, Xiawei WEI, Peng YANG, Lele ZHAO, Chen ZHANG, Ning JIANG, Wei ZHENG, Jian LI, Shuhui CHEN
  • Publication number: 20220281873
    Abstract: Disclosed is a class of porcupine inhibitors, specifically a compound as represented by formula (I), and a pharmaceutically acceptable salt or an isomer thereof.
    Type: Application
    Filed: July 8, 2020
    Publication date: September 8, 2022
    Applicant: MEDSHINE DISCOVERY INC.
    Inventors: Xiongbin XU, Yi CHEN, Cailin WANG, Ru FENG, Wen JIANG, Lingyun WU, Jian LI, Shuhui CHEN
  • Patent number: D971138
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: November 29, 2022
    Inventor: Lingyun Wu
  • Patent number: D996436
    Type: Grant
    Filed: January 6, 2022
    Date of Patent: August 22, 2023
    Assignee: SHENZHEN ORICO TECHNOLOGIES CO., LTD.
    Inventor: Lingyun Wu